Skip to content
Peptigraph home

Tesamorelin for Sleep: What the Evidence Shows

What human and animal studies show about Tesamorelin for sleep, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGHRH analogUpdated
Strongest evidence
Human RCT
Human studies
1
PubMed records, our ledger
Animal studies
0
PubMed records, our ledger
Studies we summarised
1
with an outcome for sleep

Evidence for sleep

Each row is an outcome related to sleep from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Tesamorelin for sleep: outcomes in published studies
OutcomeResultStudy typeSource
Body composition, fatigue, sleep and functionLow-dose tesamorelin did not significantly change body composition, fatigue, sleep, physical performance, glucose tolerance or cognition.Human controlled trialn = 22eNeurologicalSci 2026, PMID 42382101

PubMed records for Tesamorelin and sleep: 1 human, 0 animal (search counts, not studies we reviewed). Grades follow our .

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4eNeurologicalSci 2026, PMID 42382101

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Sleep problems

MedlinePlus describes insomnia as a common sleep disorder with trouble falling asleep, staying asleep or both.[2]

The only trial that measured sleep

PubMed gives 2 human-filtered papers and none in animals for tesamorelin plus sleep terms; only 1 survives the human-only filter and none is randomized.

Calculated from pubmed query (tesamorelin[tiab] OR Egrifta[tiab] OR TH9507[tiab] OR "TH-9507"[tiab]) AND (sleep*[tiab] OR insomni*[tiab]); date 2026-10-02; human filter count 2; human only count 1; animal filter count 0; randomized filter count 0. Formula: counts as recorded in the goals.json ledger (PubMed [tiab] query with the human, animal and RCT filters shown)

A controlled trial of low-dose GHRH compared body composition, fatigue, sleep, performance, glucose tolerance and brain measures, and found no significant changes.[1]

A trial in adults with mild cognitive impairment and healthy older adults tested GHRH for cognitive function, not sleep. The intent-to-treat analysis indicated a favorable effect on cognition (P=.03).[3]

What the label says about tesamorelin and sleep

The label's stated purpose is excess abdominal fat in HIV lipodystrophy, with no sleep indication.[4]

The label warns of fluid retention that shows as increased tissue turgor and musculoskeletal discomfort, with edema, arthralgia and carpal tunnel syndrome reported.[4]

Other peptides people research for sleep

All peptides for sleep, compared

Common questions

Does Tesamorelin help with sleep?

The strongest study we summarise for sleep is human rct evidence, across 1 study with an outcome for sleep. A trial result is not an approval; see the legal status.

Is Tesamorelin approved for sleep?

Tesamorelin is FDA approved (Egrifta). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for sleep?

There is no single answer. Our sleep overview compares each candidate by evidence grade and legal status rather than by popularity.

Does tesamorelin help you sleep?

Not in the one trial that measured sleep: low-dose GHRH was not linked with significant changes in its study measures.[1]

More on Tesamorelin

Sources

  1. 1The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.eNeurologicalSci · 2026PMID 42382101Accessed 2 Oct 2026
  2. 2medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
  3. 3Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.Archives of neurology · 2012PMID 22869065Accessed 2 Oct 2026
  4. 4EGRIFTA WR prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.